FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax's partners, all reformulated to target the XFG variant, giving clinicians several options ahead of the fall respiratory virus season.
|Articles|September 9, 2021
Biden Expected to Announce COVID-19 Vaccine Mandates on Employers
Author(s)John Parkinson
In a move that is going to be announced, the administration is going to look to mandate vaccines for any companies with 100 employees or more
Advertisement
President Biden is expected to announce new vaccine mandates for both government contractors and companies with 100 employees or more.Biden is going to direct the Department of Labor to mandate for these companies to mandate all their employees get vaccinated or face weekly testing, according to a new report from the
This is in addition to mandating federal contractors and millions of health care workers in medical institutions that receive Medicare and Medicaid funding to get vaccinated.
During a media briefing earlier today, Jen Psaki, the White House press secretary, she said federal workers would be subject to a 75-day grace period for receiving a vaccine. For those workers who refuse to get the vaccine, they will go through a process with their human resources with subject to discipline.
Biden is expected to make a speech at 5pm EDT today to discuss the measures and parts of his plan to combat COVID-19.
Advertisement
Related to this article
The Vaccine Integrity Project, in collaboration with the American Medical Association, conducted a vaccine and immunization effectiveness and safety review for RSV, Influenza, and COVID-19 for the 2026-2027 season. JAMA published the review, and here is an overview of the data going into this year's seasonal respiratory virus season.
The antiviral did not produce greater symptom improvement than placebo in patients with the condition in the RECOVER-VITAL trial.
The FDA has approved formulations for the 2026-2027 vaccines including Pfizer-BioNTech's Comirnaty XFG, Novavax's commercial partners Sanofi and Takeda have secured approvals for its Nuvaxovid, and Moderna's Spikevax and mNEXSPIKE vaccines, all with protections against the currently circulating variant.
The FDA has approved Pfizer-BioNTech's 2026-2027 Comirnaty XFG formula, an updated COVID-19 vaccine targeting the XFG variant, for adults 65 and older and for individuals ages five through 64 with at least one high-risk underlying condition.
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.